The Broker Views tell you what brokers are tipping and any that are making the news.
Friday 13 Feb 2026
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.
Friday 13 Feb 2026
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.
Friday 13 Feb 2026
(Sharecast News) - Analysts at Berenberg hiked their target price on construction firm Morgan Sindall from 5,400p to 5,800p on Friday in order to reflect another strong performance from the group's fit out division.
Thursday 12 Feb 2026
(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the stock's recent de-rating was excessive given structural drivers.
Thursday 12 Feb 2026
(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the de-rating was excessive given structural drivers.
Thursday 12 Feb 2026
(Sharecast News) - Citi downgraded Drax on Thursday to 'neutral' from 'buy' as it said the shares were already discounting much of the probability-weighted upside, but lifted the price target to 923p from 850p.
Thursday 12 Feb 2026
(Sharecast News) - Canaccord Genuity has reiterated its 'buy' rating for Dunelm following the homeware retailer's interim results this week, highlighting the company's long-term potential and strategic direction led by its new chief executive.
Thursday 12 Feb 2026
(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world".
Thursday 12 Feb 2026
(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on property developer Barratt Redrow from 450p to 425p on Thursday as it updated its estimates to account for the firm's interim results.
Wednesday 11 Feb 2026
(Sharecast News) - Canaccord Genuity lowered its target price on industrial supplies firm Flowtech Fluidpower from 130p to 100p on Wednesday, even as it said the group was "unlocking European growth".
Wednesday 11 Feb 2026
(Sharecast News) - Canaccord Genuity lowered its target price on industrial supplies firm Flowtech Fluidpower from 130p to 100p on Wednesday, even as it said the group was "unlocking European growth".
Wednesday 11 Feb 2026
(Sharecast News) - Berenberg said on Wednesday that the selloff in shares of MoneySuperMarket parent Mony Group and GoCompare owner Future a day earlier was overdone.
Wednesday 11 Feb 2026
(Sharecast News) - Analysts at Citi upgraded budget carrier EasyJet to 'buy' on Wednesday, pointing to "an easing path on the horizon".
Wednesday 11 Feb 2026
(Sharecast News) - JPMorgan upgraded homeware retailer Dunelm on Wednesday to 'overweight' from 'neutral' as it said the risk has shifted to the upside.
Tuesday 10 Feb 2026
(Sharecast News) - Analysts at Berenberg hiked their target price on motor and property lender S&U from 1,700p to 2,350p on Tuesday following the group's fourth-quarter trading update.
Tuesday 10 Feb 2026
(Sharecast News) - Croda shot to the top of the FTSE 100 on Tuesday after JPMorgan reiterated its 'overweight' rating on the shares and hiked the price target to 4,000p from 3,600p.
Tuesday 10 Feb 2026
(Sharecast News) - Analysts at Berenberg hiked their target price on motor and property lender S&U from 1,700p to 2,350p on Tuesday following the group's fourth-quarter trading update.
Monday 09 Feb 2026
(Sharecast News) - Jefferies upgraded Dunelm on Monday to 'buy' from 'hold' as it said the recent de-rating was overdone.
Monday 09 Feb 2026
(Sharecast News) - Jefferies upgraded Dunelm on Monday to 'buy' from 'hold' as it said the recent de-rating was overdone.
Monday 09 Feb 2026
(Sharecast News) - Analysts at JP Morgan raised their target price on drugmaker GSK to £22.50 on Monday on improving investor perception.
You are here: research > uk shares > broker views